Published Date: 10 Mar 2023
Today's top stories include: Nine-year cap to complete MBBS, elective-based credits offered in NMC letter Students enrolled in...
Read Full NewsA dose-dense modified Stanford V regimen may improve early complete responses and allow some pediatric patients with low-risk Hodgkin lymphoma to skip radiotherapy.
In a small phase II study of patients with KRAS G12C-mutated NSCLC, poor performance status, not advanced age, was associated with reduced treatment response.
1.
One CAR T-Cell Therapy for Multiple Myeloma Tops Another in Propensity Matched Study
2.
Safe and acceptable telehealth suicide prevention program.
3.
The Benefits of Exercise for Substance Use Disorders.
4.
Nivolumab Regimen Achieves Durable PFS in Advanced Hodgkin's Lymphoma
5.
Biomarker-Selected Treatment Shows Promise for Bladder Preservation in MIBC
1.
Lu-177 Vipivotide in Prostate Cancer: A Breakthrough in Radioligand Therapy
2.
CAR T-Cell Therapy: Revolutionizing Hematologic Malignancies
3.
A Glimmer of Hope: The Predictive Power of Liquid Biopsy and AI in Palliative Oncology
4.
Using Node Technology to Fight Breast Cancer: A New Hope for Early Detection
5.
Nuclear Medicine's Role in Battling Women's Cancers
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part I
2.
First-Line Maintenance Therapy for Metastatic Urothelial Carcinoma: Bridging Clinical Practice and Trials
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V
4.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia
5.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation